Biologic Excipients Market, By Product, By Source, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Description

REPORT HIGHLIGHT

Biologic Excipients Market size was valued at US$ 2,983.43 Million in 2024, expanding at a CAGR of 5.90% from 2025 to 2032.

Biologic Excipients are non-active components used in the formulation of biologic drugs to enhance their stability, solubility, and overall performance. Unlike active pharmaceutical ingredients (APIs), these excipients do not produce therapeutic effects but play a critical role in ensuring the efficacy, safety, and shelf-life of biologic products. Given the sensitive nature of biologics such as proteins, peptides, and monoclonal antibodies, the selection of appropriate excipients is crucial in overcoming challenges related to stability, degradation, and delivery. The need for biologic excipients arises from the complex and fragile structure of biological molecules, which are highly susceptible to environmental factors like heat, light, and pH changes. Excipients act as stabilizers to prevent protein aggregation, oxidation, or denaturation, thus preserving the drug's potency. Additionally, solubilizers and surfactants improve the solubility of poorly soluble compounds, enhancing their bioavailability and therapeutic effectiveness. Preservatives and buffering agents are essential for maintaining product sterility and pH balance, ensuring safe administration to patients. The importance of biologic excipients lies in their ability to optimize drug formulation, support large-scale production, and extend shelf-life without compromising product quality. Their proper use enhances patient outcomes, regulatory compliance, and the commercial success of biologic therapies in modern medicine.

Biologic Excipients Market- Market Dynamics

Increasing demand for biologic drugs

The increasing demand for biologic drugs is a key driver in the growth of the biologic excipients market, as biologics offer targeted, highly effective treatments for complex diseases such as cancer, autoimmune disorders, and rare genetic conditions. Biologic drugs, including monoclonal antibodies, vaccines, and cell therapies, are characterized by their complex molecular structures and greater sensitivity to environmental factors, making the use of specialized excipients essential to ensure stability, efficacy, and safety. This demand is fueled by the rising prevalence of chronic diseases globally and the expanding geriatric population requiring advanced therapeutic solutions. According to the World Health Organization (WHO), chronic diseases account for approximately 71% of all deaths worldwide, highlighting the urgent need for innovative biologic-based treatments. In response, governments and healthcare organizations are significantly increasing investments in biologic drug research and development. For instance, in the United States, biologics accounted for nearly 50% of the top 100 prescription drug sales in 2023, reflecting their growing market dominance. This trend directly impacts the biologic excipients market, as manufacturers require sophisticated excipient solutions to enhance drug formulation and delivery. As a result, the biologic excipients market is poised for significant growth, driven by the continuous development of innovative therapies and the need to meet stringent regulatory and quality standards.

Biologic Excipients Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.90% over the forecast period (2025-2032)
Based on Product segmentation, Stabilizers was predicted to show maximum market share in the year 2024
Based on Application segmentation, Biopharmaceutical Production was the leading segment in 2024
On the basis of region, North America was the leading revenue generator in 2024

Biologic Excipients Market- Segmentation Analysis:

The Global Biologic Excipients Market is segmented on the basis of Product, Source, Application and Region.

The market is divided into five categories based on Product: Solubilizers, Stabilizers, Preservatives, Buffers and Carriers. Stabilizers dominate the market due to their critical role in preventing protein aggregation, oxidation, and denaturation, which are common issues with sensitive biologic drugs. Their ability to enhance drug stability and extend shelf life makes them indispensable in biologic formulations.

The market is divided into three categories based on Application: Biopharmaceutical Production, Research and Development and Clinical Trials. Biopharmaceutical Production dominates the market because it represents the largest and most critical application segment, requiring specialized excipients to ensure the stability, efficacy, and scalability of biologic drugs during manufacturing. The growing demand for innovative biologic therapies and large-scale production needs drives the extensive use of excipients in this sector.

Biologic Excipients Market- Geographical Insights

North America dominates the market, primarily due to its well-established pharmaceutical and biotechnology industries, extensive R&D investments, and the rising prevalence of chronic diseases requiring biologic therapies. The United States, with major players and advanced research facilities, accounts for a significant market share. Additionally, favorable government initiatives and regulatory support, such as the U.S. FDA's fast-track approvals for biologics, further boost market growth. Europe represents another major region, driven by strong biopharmaceutical production capabilities, innovation in drug development, and supportive regulatory policies from agencies like the European Medicines Agency (EMA). Countries like Germany, France, and the UK lead the region in biologic drug development and production. The Asia-Pacific region is expected to witness the fastest growth due to the expanding pharmaceutical manufacturing sector, increasing investments in biologic R&D, and growing healthcare expenditures. Countries such as China and India are emerging as key players, with government-backed initiatives to boost local biologic production and exports. Rising awareness about advanced therapies and an increasing number of contract manufacturing organizations (CMOs) contribute to regional growth.

Biologic Excipients Market- Competitive Landscape:

The Biologic Excipients Market is characterized by intense competition driven by continuous innovation, technological advancements, and a growing focus on high-quality, specialized excipients tailored for complex biologic formulations. Market players compete based on product portfolios, offering stabilizers, solubilizers, and preservatives that meet stringent regulatory standards for biopharmaceutical applications. The development of multifunctional excipients with enhanced stability properties and improved biocompatibility is a key competitive strategy to gain market share. Partnerships, collaborations, and strategic alliances between excipient producers and biopharmaceutical companies are common, enabling customized solutions and joint innovation. Additionally, the rising trend of outsourcing biologic drug manufacturing has created growth opportunities for contract research and manufacturing organizations (CROs and CMOs), intensifying market dynamics. Companies are also focusing on expanding their geographic presence to capitalize on the rapid growth in emerging markets, especially in Asia-Pacific. Innovation in green and sustainable excipient production, driven by regulatory pressures and environmental concerns, is becoming a critical differentiator. Furthermore, investments in advanced research facilities and adherence to evolving regulatory guidelines enhance competitive positioning.

Recent Developments:

In July 2024, Agilent Technologies Inc. announced a definitive agreement to acquire BIOVECTRA, a Canada-based contract development and manufacturing organization (CDMO), for $925 million. This strategic acquisition aims to expand Agilent's biopharma solutions by incorporating BIOVECTRA's expertise in biologics, highly potent active pharmaceutical ingredients, and other targeted therapeutic molecules.
In November 2024, Clariant introduced a range of high-performance excipients at CPHI India 2024 to address the growing needs of the Indian healthcare market. These excipients are designed for sensitive active pharmaceutical ingredients (APIs), parenteral formulations, and colorless applications, with an emphasis on purity and bioavailability. The company is leveraging India's manufacturing capabilities to deliver customized solutions that meet global regulatory standards, ensuring the efficacy and safety of biologics and complex drug formulations.
In October 2024, Samsung Biologics launched a high-concentration formulation platform aimed at advancing the development of high-dose biologic drugs. This platform is designed to improve the delivery and efficacy of drugs with higher concentrations, streamlining the development process and meeting the increasing demand for such therapies. It supports both the manufacturing and formulation of biologics, ensuring better stability and scalability.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOLOGIC EXCIPIENTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Dow Chemical Company
BASF SE
Evonik Industries AG
Lonza Group
Wacker Chemie AG
Asahi Kasei Corporation
Clariant International Ltd.
Croda International Plc
Ingredion Incorporated
Fuji Chemical Industry Co. Ltd.
Nippon Fine Chemical Co. Ltd.
DSM Nutritional Products
Protex International
Lubrizol Corporation
Ashland Global Holdings Inc.
Others

GLOBAL BIOLOGIC EXCIPIENTS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

Solubilizers
Stabilizers
Preservatives
Buffers
Carriers
Others

GLOBAL BIOLOGIC EXCIPIENTS MARKET, BY SOURCE - MARKET ANALYSIS, 2019 - 2032

Animal-derived
Human-derived
Microbial-derived
Synthetic

GLOBAL BIOLOGIC EXCIPIENTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Biopharmaceutical Production
Research and Development
Clinical Trials

GLOBAL BIOLOGIC EXCIPIENTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV4716

1. Biologic Excipients Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Biologic Excipients Market Snippet by Product
- 2.1.2. Biologic Excipients Market Snippet by Source
- 2.1.3. Biologic Excipients Market Snippet by Application
- 2.1.4. Biologic Excipients Market Snippet by Country
- 2.1.5. Biologic Excipients Market Snippet by Region
2.2. Competitive Insights

3. Biologic Excipients Key Market Trends

3.1. Biologic Excipients Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Biologic Excipients Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Biologic Excipients Market Opportunities
3.4. Biologic Excipients Market Future Trends

4. Biologic Excipients Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Biologic Excipients Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Biologic Excipients Market Landscape

6.1. Biologic Excipients Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Biologic Excipients Market - By Product

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
- 7.1.2. Solubilizers
- 7.1.3. Stabilizers
- 7.1.4. Preservatives
- 7.1.5. Buffers
- 7.1.6. Carriers
- 7.1.7. Others

8. Biologic Excipients Market - By Source

8.1. Overview
- 8.1.1. Segment Share Analysis, By Source, 2024 & 2032 (%)
- 8.1.2. Animal-derived
- 8.1.3. Human-derived
- 8.1.4. Microbial-derived
- 8.1.5. Synthetic

9. Biologic Excipients Market - By Application

9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 9.1.2. Biopharmaceutical Production
- 9.1.3. Research and Development
- 9.1.4. Clinical Trials

10. Biologic Excipients Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Biologic Excipients Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Biologic Excipients Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.8. UK
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.8.4. UK Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.3.8.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.9. France
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.9.4. France Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.3.9.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.10. Italy
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.10.4. Italy Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.3.10.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.11. Spain
  - 10.3.11.1. Overview
  - 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Spain Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.3.11.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.12. The Netherlands
  - 10.3.12.1. Overview
  - 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.12.4. The Netherlands Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.3.12.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Overview
  - 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.3.13.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.14. Russia
  - 10.3.14.1. Overview
  - 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Russia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.3.14.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.15. Poland
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Poland Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.16. Rest of Europe
  - 10.3.16.1. Overview
  - 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.16.4. Rest of the Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Biologic Excipients Key Manufacturers in Asia Pacific
- 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.5. APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
- 10.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.7. China
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.7.4. China Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.4.7.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.8. India
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.8.4. India Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.12. Indonesia
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Indonesia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.13. Thailand
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Thailand Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
- 10.5.1. Overview
- 10.5.2. Biologic Excipients Key Manufacturers in Latin America
- 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.5.5. LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
- 10.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
- 10.6.1. Overview
- 10.6.2. Biologic Excipients Key Manufacturers in Middle East and Africa
- 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.5. MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
- 10.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.8. UAE
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.6.8.4. UAE Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.6.8.5. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Biologic Excipients Industry

11.1. Competitive Dashboard
- 11.1.1. Competitive Benchmarking
- 11.1.2. Competitive Positioning
11.2. Company Profiles
- 11.2.1. Dow Chemical Company
- 11.2.2. BASF SE
- 11.2.3. Evonik Industries AG
- 11.2.4. Lonza Group
- 11.2.5. Wacker Chemie AG
- 11.2.6. Asahi Kasei Corporation
- 11.2.7. Clariant International Ltd.
- 11.2.8. Croda International Plc
- 11.2.9. Ingredion Incorporated
- 11.2.10. Fuji Chemical Industry Co. Ltd.
- 11.2.11. Nippon Fine Chemical Co. Ltd.
- 11.2.12. DSM Nutritional Products
- 11.2.13. Protex International
- 11.2.14. Lubrizol Corporation
- 11.2.15. Ashland Global Holdings Inc.
- 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us